CAS: 201335-88-8; Fmoc-D-Tyr(Me)-Oh

该化合物是D-tyrosine受保护的衍生物,由N终点端的氟基甲基氧碳基(Fmoc)组组成,对苯球氢氧基组实行甲基醚保护,该化合物因其在基本条件下的稳定性和与基于氟化物的战略的兼容性而广泛用于固态阶段的peptide合成(SPPS).甲基醚保护防止在Peptide延长期间出现意外的侧面反应,同时保持与其他保护组的正反向性.其D的配置使其具有价值,有助于以强化的代谢稳定性或特定性能要求建造peptides.该产品的特征是,在自动合成中具有很高的纯度和可靠性能,确保有效融入复杂的pited序列.

结构式图片

相似化合物

1260595-45-6 39878-65-4 141895-35-4

欧盟法规

C&L通报

上下游产品

(fluorenylmethoxy)carbonyl chloride O-methyl-L-tyrosine O-Methyltyrosine N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide1]-alloferon[Phe(p-OMe)1]-alloferon 40H48N6O5C40H48N6O5 Carbet°Cin

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:EP-3515880-B1
    优先权日:2017-03-17
    标题:Methods and compositions for synthesis of encoded libraries
    发明人:LI JIN; MORGAN BARRY A; Wan jinqiao; DOU DENGFENG; LIU GUANSAI; CHANG YONG; CHEN QIUXIA; WANG XING; XU YANSHAN; HU DONGYAN; LIU JIAN; CHENG XUEMIN
    权利人:HITGEN INC

    专利号:US-8338565-B2
    优先权日:2008-08-20
    标 题 :Macrocyclic compounds for inhibition of tumor necrosis factor alpha
    发明人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P
    权利人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P; ENSEMBLE THERAPEUTICS CORP
    摘要:Disclosed herein are macrocyclic compounds and methods for their synthesis and use. In particular, macrocyclic compounds are disclosed that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-950.

    合成参考文献

    合成方法参考DOI号:10.1002/chem.201501799
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知